double-dummy
Showing 1 - 25 of >10,000
Allergic Rhinitis Trial in São Paulo (Administration of investigation of Eurofarma drug, Administration of Comparator)
Not yet recruiting
- Allergic Rhinitis
- Administration of investigation of Eurofarma drug
- Administration of Comparator
-
São Paulo, BrazilEurofarma Laboratorios S.A
Dec 12, 2022
Urinary Tract Infection, Acute Pyelonephritis Trial (TBP-PI-HBr, Imipenem-cilastatin, Dummy Infusion)
Not yet recruiting
- Urinary Tract Infection
- Acute Pyelonephritis
- TBP-PI-HBr
- +3 more
- (no location specified)
Sep 22, 2023
Essential Hypertension Trial (NW Roselle, Captopril 25Mg Tab)
Not yet recruiting
- Essential Hypertension
- NW Roselle
- Captopril 25Mg Tab
- (no location specified)
Nov 15, 2023
Overweight, Obesity Trial in São Paulo (ADF1 Group Eurofarma drug association of Sibutramine IR 15mg / Topiramate XR 75mg, ADF2
Not yet recruiting
- Overweight
- Obesity
- ADF1 Group Eurofarma drug association of Sibutramine IR 15mg / Topiramate XR 75mg
- +3 more
-
São Paulo, SP, BrazilHC-FMUSP
Jul 28, 2022
COPD Trial (HRG2005 inhalation, Placebo to match HRG2005 inhalation, Placebo to match Indacaterol Maleate and Glycopyrronium
Not yet recruiting
- Chronic Obstructive Pulmonary Disease
- HRG2005 inhalation
- +3 more
- (no location specified)
Sep 7, 2023
Diabetes, Type 2 Trial (NW Low-Glu®, Metformin)
Not yet recruiting
- Diabetes Mellitus, Type 2
- NW Low-Glu®
- Metformin
- (no location specified)
Nov 20, 2023
Abuse Potential Trial in Salt Lake City (gabapentin 600 mg, gabapentin 1200 mg, gabapentin 1800 mg)
Completed
- Abuse Potential
- gabapentin 600 mg
- +4 more
-
Salt Lake City, UtahPharmaceutical Research Associates, Inc.
Dec 22, 2022
Helicobacter Pylori Infection Trial in Beijing (Tegoprazan)
Not yet recruiting
- Helicobacter Pylori Infection
-
Beijing, Beijing, ChinaPeking University Third Hospital
Oct 9, 2022
Healthy Trial in Melbourne (PUR3100, Dihydroergotamine (D.H.E 45), Matching Placebo for PUR3100)
Recruiting
- Healthy
- PUR3100
- +3 more
-
Melbourne, Victoria, AustraliaNucleus Network Melbourne
Jun 23, 2022
Pain Trial (FDC of codeine 30 mg/dipyrone 500 mg, Tylex)
Not yet recruiting
- Pain
- FDC of codeine 30 mg/dipyrone 500 mg
- Tylex
- (no location specified)
Aug 10, 2022
Acute Ischemic Stroke, Large Vessel Occlusion, Reperfusion Trial (Low-dose Y-6 sublingual tablets, High-dose Y-6 sublingual
Not yet recruiting
- Acute Ischemic Stroke
- +2 more
- Low-dose Y-6 sublingual tablets
- +4 more
- (no location specified)
Nov 14, 2023
Reflux Esophagitis, Gastroesophageal Reflux, Esophagitis Trial in Shanghai (Anaprazole sodium 40 mg, Anaprazole sodium 60 mg,
Not yet recruiting
- Reflux Esophagitis
- +6 more
- Anaprazole sodium 40 mg
- +2 more
-
Shanghai, Shanghai, ChinaShanghai Changhai Hospital
Nov 1, 2022
Pain Trial in Brooklyn (Ketamine via Intravenous, Ketamine via BAN)
Recruiting
- Pain
- Ketamine via Intravenous
- Ketamine via BAN
-
Brooklyn, New YorkMaimonides Medical Center
Oct 19, 2022
Telogen Effluvium Trial (BL 3000, Reference Pantogar, BL3000 Placebo)
Not yet recruiting
- Telogen Effluvium
- BL 3000
- +3 more
- (no location specified)
Jul 5, 2022
Primary Dysmenorrhea Trial in São Paulo (CDE100 association, Buscopan® Composto association)
Not yet recruiting
- Primary Dysmenorrhea
- CDE100 association
- Buscopan® Composto association
-
São Paulo, SP, BrazilInvestigational Site
Jan 16, 2023
Herpetic Neuralgia Trial in Wuhan (HSK16149 20mg BID, HSK16149 40mg BID, Pregabalin 150mg)
Recruiting
- Herpetic Neuralgia
- HSK16149 20mg BID
- +2 more
-
Wuhan, Hubei, ChinaUnion Hospital, Tongji Medical College, Huazhong University of S
Feb 28, 2023
Uncomplicated Urinary Tract Infections Trial in Anniston, La Mesa, Chicago (GSK3882347, Nitrofurantoin, Placebo)
Recruiting
- Uncomplicated Urinary Tract Infections
- GSK3882347
- +2 more
-
Anniston, Alabama
- +4 more
Dec 2, 2022
Chronic Spontaneous Urticaria Trial (Remibrutinib, Placebo to remibrutinib, Placebo to omalizumab)
Not yet recruiting
- Chronic Spontaneous Urticaria
- Remibrutinib
- +3 more
- (no location specified)
Sep 20, 2023
Androgenetic Alopecia Trial (Finlândia Association + finasteride , Minoxidil + finasteride)
Not yet recruiting
- Androgenetic Alopecia
- Finlândia Association + finasteride placebo
- Minoxidil + finasteride
- (no location specified)
Aug 3, 2022